Clearance of vasopressin and copeptin during hemodialysis

Completed

• Conditions: End Stage Renal Disease; 10038430

• Registration Number: NL-OMON42330
• Lead Sponsor: Interne Geneeskunde, Nefrologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

Thrice-weekly dialysis schedule, dialysis with a shunt.

Exclusion Criteria

Age under 18
Dialysis frequency other than thrice weekly
Dialysis duration other than 4 hours
Dialysis with a central venous catheter

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Plasma vasopressin and copeptin levels before and during hemodialysis</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Niet van toepassing / not applicable</p><br>